
Carrie L Kitko MD
Associate Professor of Pediatrics Medical Director, Pediatric Stem Cell Transplant Program
Join to View Full Profile
3601 The Vanderbilt ClinicNashville, TN 37232
Phone+1 615-322-3000
Dr. Kitko is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Pediatric Hematology/Oncology, 2003 - 2006
Duke University HospitalChief Residency, Pediatrics, 2002 - 2003
Duke University HospitalResidency, Pediatrics, 1999 - 2002
Ohio State University College of MedicineClass of 1999
Denison UniversityB.S., Summa Cum Laude, 1991 - 1995
Certifications & Licensure
TN State Medical License 2015 - 2026
AL State Medical License 2017 - 2024
MI State Medical License 2003 - 2016
NC State Medical License 1999 - 2004
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
- Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
- Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- Factors Associated With Pre-donation Health-related Quality-of-Life Among Pediatric Sibling Hematopoietic Cell Donors: A DonorKids QL Study.Galen E Switzer, Jessica G Bruce, Bronwen E Shaw, Vidya Kuniyil, James W Varni
Transplantation and Cellular Therapy. 2026-07-01 - Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" Trial.Betty K Hamilton, Lynn Onstad, Paul A Carpenter, Joseph Pidala, George Chen
American Journal of Hematology. 2026-07-01 - Skin Lesion Reconstruction in Graft Versus Host Disease Using Autograft From the Bone Marrow Donor Panniculectomy Tissue.Daniella King, Maria Kalogeromitros, Barite Gutama, Hanna L Slutsky, Ronnie Mubang
Annals of Plastic Surgery. 2026-06-11
Journal Articles
- TNF-inhibition with etanercept for graft versus host disease prevention in high risk HCT: Lower TNFR1 levels correlate with better outcomeChoi SW, Stiff P, Cooke K, Ferrara JLM, Braun T, Kitko C, Reddy P, Yanik G, Mineishi S, Paczesny S, Hanauer D, Pawarode A, Peres E, Rodriguez T, Smith S, Levine JE, Biol Blood Marrow Transplant, 1/1/2012
- Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcome after unrelated donor transplantation for ch...Veys P, Wynn RF, Ahn KW, Samarasinghe S, He W, Bonney D, Craddock J, Cornish J, Davies SM, Dvorak CC, Duerst RE, Gross TG, Kapoor N, Kitko C, Krance RA, Leung W, Lewis..., Blood, 1/1/2012
- Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesMagenau J, Tobai H, Pawarode A, Braun T, Peres E, Reddy P, Kitko C, Choi S, Yanik G, Frame D, Harris A, Erba H, Kujawski L, Elenitoba-Johnson K, Sanks J, Jones D, Pacz..., Blood, 1/1/2011
Books/Book Chapters
Abstracts/Posters
- The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host DiseaseCarrie Kitko, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Prepa...Carrie Kitko, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Prednisone (PDN)/Sirolimus (SRL) compared to PDN/SRL/Calcineurin Inhibitor (CNI) as treatment for chronic graft-versus-host-disease (cGVHD): A randomized phase II stud...Carpenter P, Logan B, Lee S, Weisdorf D, Johnston L, Costa L, Kitko C, Bolanos-Meade J, Alousi, A, Horowitz M, Abhyankar S, Waller E, Mendizabal A, Wang Y, Lazaryan A,..., American Society of Blood and Marrow Transplant Meeting, Honolulu, HI, 1/1/2016
Lectures
- Efficacy of Methoxsalen Sterile Solution in Conjunction with the Therakos¬ Cellex¬ Photopheresis System in Pediatric Patients with Steroid-Refractory Acute GvHD: Inter...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Highlights from ASH 2014: Pediatric Hematology/OncologyDearborn, MI - 1/1/2015
- Chronic GVHD Biomarker Discovery: A Pathway to Better Treatments1/1/2014
Press Mentions
Children Benefit in Multiple Ways from Cellular Therapy AdvancementsSeptember 23rd, 2025- High-Dose Flu Vaccine Beneficial for Pediatric Stem Cell Transplant PatientsMarch 2nd, 2023
- Syndax Pharmaceuticals and Incyte Announce Axatilimab Phase 1/2 Data in Patients with Chronic Graft-Versus-Host Disease Published in the Journal of Clinical OncologyDecember 5th, 2022
Committees
- Committee member, ASH Communications Committee
Professional Memberships
- American Society for Blood and Marrow TransplantationMember
External Links
- Vanderbilt Pediatric Stem Cell Transplanthttp://www.childrenshospital.vanderbilt.org/services.php?mid=1248
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









